Alejandro Luna F.

Alejandro Luna joined OLIVARES in 1996 and became a partner in 2005. He is instrumental in the IP Litigation, Regulatory and Administrative Litigation practices and Co-chair of the Life Sciences & Pharmaceutical law and industry group and also he coordinates the litigation department. Mr. Luna has been crucial to the heart of Mexico’s intellectual property legal system as one of the few true patent-regulatory litigation experts in Mexico. He acts on behalf of his clients as an attorney and a lobbyist.

Mr. Luna has participated in questioning the constitutionality of certain provisions of the Industrial Property Law and the Federal Copyright Law. In order to make more accessible the monetary compensation derived from the violation of IP rights, he is the sponsor of an important proposal to modify the system of litigation and enforcement of IP rights in Mexico.

Mr. Luna has spearheaded a ten-year litigation strategy that has incorporated regulation changes and lobbying which has resulted in an important precedent for the patent linkage regulation and life terms of pipeline patents in Mexico. As a result of his involvement, he has been selected as the delegate to represent AMIIF, the industry association for R&D pharmaceutical companies who do business in Mexico, in the Trans-Pacific Partnership (TPP) negotiations.

His practice is not solely devoted to Life Sciences; he represents clients across a myriad of industries. Alejandro Luna has successfully litigated for pharmaceutical patents and pioneered administrative court actions to seek recognition of DPE rights (protection for safety and efficacy data), which are not specifically recognized by Mexican laws.

He is currently involved in a NAFTA arbitration related to the interpretation of the Patent Law in North America and also appealed refusals of authorizations for medicines containing “cannabis”; Mr. Luna considers that the authorization should be granted for cannabis and other narcotics for medical use and through the proper abuse-deterrent formulations.

His commitment to just and fair law extends to his overall promise of client satisfaction; he lobbies to change the law to allow for proper patent protection and best serve his clients. Mr. Luna is also the author of several articles on patents, litigation and regulatory issues (pharma, food and beverages regulation). He is a part-time professor at the Universidad Nacional Autónoma de México (UNAM), for the IP Master of Law and the Health Law Diploma.


  • Franklin Pierce Law Center
    LLM, Intellectual Property Law, 2002
  • Universidad Panamericana
    Diploma on Amparo Law, 2000
  • Universidad Latinoamericana
    Juris Doctor, 1996


  • Asociación Mexicana de Industrias de Investigación Farmacéutica, AC (AMIIF)
  • Asociación Mexicana para la Protección de la Propiedad Intelectual (AMPPI)
  • Barra Mexicana de Abogados (BMA)
  • Biotechnology Industry Organization (BIO)
  • International Association for the Protection of Intellectual Property (AIPP
  • International Bar Association (IBA)
  • International Trademark Association (INTA)


  • Chambers Global – Mexico, Band 1
  • Chambers Latin America – IP, Band 1
  • Chambers Latin America – Life Sciences, Band 1
  • IAM Patent 1000 – Litigation, Gold
  • Latin Lawyer 250, Tier 1
  • Legal 500, Tier 1
  • MIP – IP Star
  • Who’s Who Legal, Tier 1
  • World’s Guide to the Leading Patent Law Practitioners, Tier 1
  • WTR 1000 – Silver – Enforcement & Litigation


  • English
  • Spanish